• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

枸橼酸盐血浆中1型纤溶酶原激活物抑制剂的抗原水平:血小板贡献的测定

Antigen levels of plasminogen activator inhibitor type 1 in citrated plasma: determination of the contribution of platelets.

作者信息

Grimaudo V, Bachmann F, Kruithof E K

机构信息

Department of Medicine, University Hospital Center, Lausanne, Switzerland.

出版信息

Haemostasis. 1990;20(6):329-33. doi: 10.1159/000216146.

DOI:10.1159/000216146
PMID:2151572
Abstract

To estimate the extent of the release of plasminogen activator inhibitor type 1 (PAI-1) from platelets following their accidental activation in vitro during blood collection, we studied the antigen levels of PAI-1 and beta-thromboglobulin (beta TG) in plasma and sera from 38 healthy volunteers. For each volunteer, we calculated the ratio of platelet-derived PAI-1/platelet-derived beta TG from the difference in their respective concentrations in serum and plasma. The mean +/- SD (0.012 +/- 0.003) and median (0.012) ratios were identical before and after 10 or 20 min of venous occlusion. The platelet contribution of PAI-1 in plasma was estimated by multiplying the plasma concentration of beta TG (as a marker of platelet activation) with the above-mentioned individual ratio. Under our conditions of blood collection (1/10 vol of 0.1 M citrate, pH 4.5, as anticoagulant, and handling of blood at 4 degrees C and within 30 min), the platelet contribution to the PAI-1 concentration in plasma was on average 12% and always negligible in plasma with high levels of PAI-1.

摘要

为了评估在血液采集过程中血小板意外体外激活后纤溶酶原激活物抑制剂1(PAI - 1)的释放程度,我们研究了38名健康志愿者血浆和血清中PAI - 1及β - 血小板球蛋白(βTG)的抗原水平。对于每位志愿者,我们根据血清和血浆中各自浓度的差异计算血小板源性PAI - 1/血小板源性βTG的比值。静脉闭塞10或20分钟前后,平均±标准差(0.012±0.003)及中位数(0.012)比值相同。通过将血浆中βTG的浓度(作为血小板激活的标志物)与上述个体比值相乘来估算血浆中PAI - 1的血小板贡献。在我们的血液采集条件下(使用1/10体积的0.1M柠檬酸盐,pH 4.5作为抗凝剂,并在4℃下30分钟内处理血液),血小板对血浆中PAI - 1浓度的贡献平均为12%,在PAI - 1水平较高的血浆中始终可忽略不计。

相似文献

1
Antigen levels of plasminogen activator inhibitor type 1 in citrated plasma: determination of the contribution of platelets.枸橼酸盐血浆中1型纤溶酶原激活物抑制剂的抗原水平:血小板贡献的测定
Haemostasis. 1990;20(6):329-33. doi: 10.1159/000216146.
2
Plasminogen activator inhibitor 1: development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation.纤溶酶原激活物抑制剂1:放射免疫分析法的建立及关于其在静脉阻塞期间和血小板聚集后血浆浓度的观察
Blood. 1987 Nov;70(5):1645-53.
3
The effect of various anticoagulant/antiplatelet mixtures on determination of plasminogen activator inhibitor, platelet proteins and hemostasis parameters.各种抗凝剂/抗血小板混合物对纤溶酶原激活物抑制剂、血小板蛋白及止血参数测定的影响。
Thromb Haemost. 1989 Jun 30;61(3):511-6.
4
Studies on the release of a plasminogen activator inhibitor by human platelets.关于人血小板释放纤溶酶原激活物抑制剂的研究。
Thromb Haemost. 1986 Apr 30;55(2):201-5.
5
Contribution of platelets to increased plasminogen activator inhibitor type 1 in severe preeclampsia.
Thromb Haemost. 1990 Jun 28;63(3):361-6.
6
Acetylsalicylic acid inhibits platelet PAI-1 antigen release without affecting circulating PAI-1 antigen in plasma.乙酰水杨酸抑制血小板纤溶酶原激活物抑制因子-1(PAI-1)抗原释放,而不影响血浆中循环的PAI-1抗原。
Ric Clin Lab. 1990 Apr-Jun;20(2):113-7. doi: 10.1007/BF02877557.
7
Plasma levels of plasminogen activator inhibitor type 1, beta-thromboglobulin, and fibrinopeptide A before, during, and after treatment of acute myocardial infarction with alteplase.用阿替普酶治疗急性心肌梗死之前、期间及之后血浆中1型纤溶酶原激活物抑制剂、β-血小板球蛋白和纤维蛋白肽A的水平。
Blood. 1991 Sep 15;78(6):1490-5.
8
The platelet and plasma pools of plasminogen activator inhibitor (PAI-1) vary independently in disease.纤溶酶原激活物抑制剂(PAI-1)的血小板池和血浆池在疾病中各自独立变化。
Br J Haematol. 1990 Aug;75(4):543-8. doi: 10.1111/j.1365-2141.1990.tb07796.x.
9
Induction of plasminogen activator inhibitor by products released from platelets.血小板释放产物对纤溶酶原激活物抑制剂的诱导作用。
Circulation. 1990 Oct;82(4):1485-93. doi: 10.1161/01.cir.82.4.1485.
10
The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays.血浆中残留血小板对纤溶酶原激活物抑制剂-1及纤溶酶原激活物抑制剂-1相关检测的影响。
PLoS One. 2017 Feb 3;12(2):e0171271. doi: 10.1371/journal.pone.0171271. eCollection 2017.

引用本文的文献

1
Treatment with Sildenafil Improves Insulin Sensitivity in Prediabetes: A Randomized, Controlled Trial.西地那非治疗可改善糖尿病前期的胰岛素敏感性:一项随机对照试验。
J Clin Endocrinol Metab. 2015 Dec;100(12):4533-40. doi: 10.1210/jc.2015-3415. Epub 2015 Nov 18.
2
Plasminogen Activator Inhibitor 1: Molecular Aspects and Clinical Importance.纤溶酶原激活物抑制剂1:分子层面及临床意义
J Thromb Thrombolysis. 1995;2(3):187-193. doi: 10.1007/BF01062709.